Vivimed Labs
Vivimed Labs Share Price Chart
Vivimed Labs last traded at ₹7.11 (2026-10-13). Over the past month the stock moved +14.9%, three months the stock moved +8.5%, year the stock moved +40.0%. Its closing range over 52 weeks is ₹4.93 – ₹25.19, with the latest close 71.8% below the high.
Closing prices up to 2026-10-13.
About Vivimed Labs
Vivimed Labs Ltd, established in 1988, is primarily engaged in the Business of Active Pharmaceuticals Ingredients, CDMO Finished Dosage Formulation, Specialty Chemicals and Retail Branded Formulation manufacturing.[1][2]
Special Resolution[1] In Dec'25, Under Special Resolution Company asked for approval for making an application to initiate a pre-packaged insolvency resolution process under the Insolvency and Bankruptcy Code, 2016, which was approved by shareholders.
Fundamentals
Quarterly Results
In the latest quarter (Mar 2026), Vivimed Labs reported sales of ₹12.00 crore (-53.8%) and net profit of ₹-147.00 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 12.00 | -140.00 | -1,169.00 | -147.00 | -17.74 |
| Dec 2025 | 16.00 | -11.00 | -68.00 | -17.00 | -2.00 |
| Sep 2025 | 21.00 | -1.00 | -4.60 | -7.00 | -0.88 |
| Jun 2025 | 21.00 | 0.00 | -1.30 | -5.00 | -0.66 |
| Mar 2025 | 26.00 | -2.00 | -10.00 | -6.00 | -0.68 |
| Dec 2024 | 37.00 | 1.00 | 2.90 | -6.00 | -0.72 |
| Sep 2024 | 25.00 | -1.00 | -2.60 | -5.00 | -0.62 |
| Jun 2024 | 29.00 | -11.00 | -37.00 | -15.00 | -1.84 |
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -17.1% | -26.5% | -9.8% | -33.3% | -27.6% | -16.0% | -56.8% | -53.8% |
| Operating profit growth | – | – | +0.0% | – | – | – | -1200.0% | – |
| Net profit growth | – | – | – | -220.0% | – | – | – | – |
| EPS growth | – | – | – | -207.9% | – | – | – | – |
| OPM % | -37.0% | -2.6% | 2.9% | -10.0% | -1.3% | -4.6% | -68.0% | -1169.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Vivimed Labs reported sales of ₹70.00 crore (-39.7%) and net profit of ₹-176.00 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 70.00 | -152.00 | -218.00 | -176.00 | -21.28 |
| Mar 2025 | 116.00 | -13.00 | -11.00 | -32.00 | -3.85 |
| Mar 2024 | 149.00 | -33.00 | -22.00 | -45.00 | -5.48 |
| Mar 2023 | 187.00 | -187.00 | -100.00 | -329.00 | -39.62 |
| Mar 2022 | 237.00 | -8.00 | -3.00 | -68.00 | -8.16 |
| Mar 2021 | 861.00 | 32.00 | 4.00 | -72.00 | -8.67 |
| Mar 2020 | 1,059 | 10.00 | 1.00 | -109.00 | -13.16 |
| Mar 2019 | 1,315 | 180.00 | 14.00 | 57.00 | 6.95 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +10.9% | -19.5% | -18.7% | -72.5% | -21.1% | -20.3% | -22.1% | -39.7% |
| Operating profit growth | -16.3% | -94.4% | +220.0% | -125.0% | – | – | – | – |
| Net profit growth | -25.0% | -291.2% | – | – | – | – | – | – |
| EPS growth | -26.4% | -289.4% | – | – | – | – | – | – |
| OPM % | 14.0% | 1.0% | 4.0% | -3.0% | -100.0% | -22.0% | -11.0% | -218.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Vivimed Labs.
Get Free AI Stock Analysis FREE →Latest News
No recent news available for Vivimed Labs.
Frequently Asked Questions
What is the share price of Vivimed Labs today?
Vivimed Labs shares were last quoted at ₹7.11 (-1.9% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Vivimed Labs?
Vivimed Labs has a price-to-earnings (P/E) ratio of -0.26 and a price-to-book (P/B) ratio of 0.00. The industry P/E is 53.33.
What is the 52-week high and low of Vivimed Labs?
The 52-week high of Vivimed Labs is ₹27.99 and the 52-week low is ₹4.76.
What is the market cap of Vivimed Labs?
The market capitalisation of Vivimed Labs is about ₹44.94 crore.
How did Vivimed Labs perform in its latest quarterly results?
In the latest quarter (Mar 2026), Vivimed Labs reported sales of ₹12.00 crore (-53.8%) and net profit of ₹-147.00 crore, compared with the same quarter last year.
Is Vivimed Labs a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Vivimed Labs has 3-year profit growth of 14.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Vivimed Labs?
Promoters hold about 7.57% of Vivimed Labs.
Which sector does Vivimed Labs belong to?
Vivimed Labs belongs to the Pharmaceuticals & Drugs sector.